Answers are grounded in this paper and cite their sources.
Whether eight triglyceride-glucose (TyG)-related indices are linked to the loss of intrinsic capacity (IC) in older adults remains unclear. This research was designed to evaluate the prospective associations linking eight TyG-based metabolic parameters to the loss of intrinsic capacity in a Chinese population-based cohort. Utilizing information from the China Health and Retirement Longitudinal Study (CHARLS), the present study identified 1,424 individuals aged 60 or older with no evidence of intrinsic capacity impairment at baseline. By calculating eight baseline TyG-related indices and employing Cox proportional hazards regression models, restricted cubic spline (RCS) analysis, and time-dependent receiver operating characteristic (ROC) curves, the present investigation comprehensively examined the associations, dose-response gradients, and prognostic value of these indicators for IC decline. The participants had a mean age of 67.45 ± 5.85 years, and 788 (55.33%) were female. Follow-up data revealed that 575 participants (40.38%) experienced a loss of intrinsic capacity. In the fully adjusted Cox model, TyG showed the highest point estimate of association (HR = 2.67, 95%CI: 1.69–4.20), followed by TyG-ABSI (HR = 2.30, 95%CI: 1.49–3.55) and TyG-BMI (HR = 2.08, 95%CI: 1.39–3.11). Dose-response analysis indicated that TyG-BMI ( P -nonlinear = 0.003) and TyG-BRI ( P -nonlinear = 0.002) showed approximately non-linear positive correlations, whereas the remaining indices exhibited linear relationships. All indicators showed poor discriminative ability for intrinsic capacity decline, with AUC values approximating 0.55. In this CHARLS cohort, all eight TyG-derived indices were positively associated with increased risk of IC deterioration. However, the limited discriminatory performance of all eight indices suggests that they may have limited utility as standalone screening tools for IC decline. Combining these metabolic indices with other clinical indicators or biomarkers and further elucidating their underlying biological pathways may help improve risk stratification and inform strategies for healthy aging.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: